• Home
  • Our Focus
    • Chronic Pain Markets
    • Gene Therapy
    • The Adolore Solution
  • Pipeline
    • Pipeline
    • ADB101 - Erythromelalgia
    • ADB102 - Osteoarthritis
  • News
    • Press Releases
    • Publications
  • About Us
    • Management
    • Board of Directors
  • Contact
  • More
    • Home
    • Our Focus
      • Chronic Pain Markets
      • Gene Therapy
      • The Adolore Solution
    • Pipeline
      • Pipeline
      • ADB101 - Erythromelalgia
      • ADB102 - Osteoarthritis
    • News
      • Press Releases
      • Publications
    • About Us
      • Management
      • Board of Directors
    • Contact
  • Home
  • Our Focus
    • Chronic Pain Markets
    • Gene Therapy
    • The Adolore Solution
  • Pipeline
    • Pipeline
    • ADB101 - Erythromelalgia
    • ADB102 - Osteoarthritis
  • News
    • Press Releases
    • Publications
  • About Us
    • Management
    • Board of Directors
  • Contact

Adolore Biotherapeutics, Inc.

Adolore Biotherapeutics, Inc. Adolore Biotherapeutics, Inc. Adolore Biotherapeutics, Inc.

Treating pain for what it is: A DISEASE


Disease-Modifying Next Generation Non-opioid Analgesic Gene Therapy for Pain


Adolore Biotherapeutics, Inc.

Adolore Biotherapeutics, Inc. Adolore Biotherapeutics, Inc. Adolore Biotherapeutics, Inc.

Treating pain for what it is: A DISEASE


Disease-Modifying Next Generation Non-opioid Analgesic Gene Therapy for Pain


Our Focus

Chronic Pain Markets

Chronic Pain Markets

Chronic Pain Markets

Gene Therapy

Chronic Pain Markets

Chronic Pain Markets

Adolore's Solution

Chronic Pain Markets

Adolore's Solution

Adolore Biotherapeutics, Inc.

13685 Whistler Mountain Road, Delray Beach, Florida 33446, United States

mlevitt@adolore.com

Copyright © 2023 Adolore - All Rights Reserved.

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept